通过使用基因表达数据库的数据驱动方法,发现了PRMT6遗传多态与Helicobacter pylori诱导的胃粘膜缩的关联
Tatsuo Inamine1, Ami Kakihara2, Yuna Tazoe2
1Department of Pharmacotherapeutics, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan; Organization for Research Promotion, University of the Ryukyus, 1 Senbaru, Nishiraha, Okinawa, 903-0213, Japan.
Microbial pathogenesis
|June 16, 2025
概括
在感染Helicobacter pylori的个体中,PRMT6基因的特定遗传变异 (SNP rs9435441) 与胃粘膜缩 (GMA) 有关. 这一发现突显了GMA发育中的新型遗传因素.
科学领域:
- 遗传学 遗传学 是一个
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
背景情况:
- 杆菌感染是慢性胃炎的主要原因,导致胃粘膜缩 (GMA),肠道转化和胃癌.
- 之前对GMA的遗传研究依赖于基于已知的功能的全基因组或候选基因方法.
- 这项研究采用了数据驱动的方法来识别候选基因,使用公开可用的数据库,独立于先前的功能知识.
研究的目的:
- 在持久性Helicobacter pylori感染的个体中识别与胃粘膜缩 (GMA) 相关的新型遗传因素.
- 为了研究单核酸多态 (SNP) 和基因表达变异在对H. pylori感染的反应之间的关系.
- 用数据驱动的方法发现GMA的候选基因,而没有先前存在的功能假设.
主要方法:
- 利用基因表达综合数据库来识别由于H. pylori感染而差异表达的基因.
- 从GTEx门户网站获取了胃部的cis-expression量化特征位置 (cis-eQTL) 数据.
- 选择了两个数据集之间的共享基因作为候选基因,并分析了195名H. pylori阳性个体.
- 在四个选定的基因 (ADORA2B,ZFAND2A,APOBEC3B和PRMT6) 中检查了四个SNP与GMA敏感性相关.
主要成果:
- 四个不同的基因内的四个SNP被确定为与GMA相关的潜在候选者.
- 在PRMT6基因中的单核酸多态 rs9435441 显示出与GMA的显著关联.
- 这种关联在小等位基因主导模型下特别强烈 (p = 0.0004,OR = 2.858).
结论:
- 在PRMT6基因中的SNP rs9435441与H. pylori感染个体胃粘膜缩的易感性显著相关.
- 这一发现表明PRMT6和GMA之间存在一种新的遗传联系,这可能仅仅通过功能性研究而不明显.
- 需要在不同种群中进行进一步的验证和功能实验,以阐明PRMT6在GMA病原发生中的确切作用.
相关概念视频
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
84
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
84
01:29Pharmacogenomics: Identification of New Drug Targets
129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129
01:26Gastritis II: Pathophysiology
87
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
87